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a  b  s  t  r  a  c  t
Members  of  the  Astroviridae  family  are  best known  to cause  diarrhea  in  different  mammalian  species.
Lately,  some  strains  have  been  associated  with  encephalitis  in  humans,  minks  and  cattle.  In this  study,  we
developed  an  immunohistochemistry  (IHC)  procedure  for  the detection  of a neurotropic  bovine  astrovirus
(BoAstV-CH13/NeuroS1),  which  is  associated  with  non-suppurative  encephalitis  in  cattle.  We  expressed
ﬁve  recombinant  antigens  corresponding  to different  putative  viral  proteins  of  BoAstV-CH13/NeuroS1.
Antigens were  then  used  for  the production  of  hyperimmune  sera  in  rabbits.  Out  of  the  ﬁve hyperimmune
sera,  the  one  directed  against  the  conserved  N-terminus  of  the  viral  capsid  protein,  termed  ORF2-con,
clearly  surpassed  the  others  in the  detection  of  viral  antigens  in IHC  in terms  of  strong  signal intensity  and
low  background  staining.  The  accuracy  of the  ORF2-con  IHC  protocol  was  then  evaluated  using  different
sets  of  brain  tissue  samples:  30 samples  from  9 animals  with  conﬁrmed  BoAstV-CH13/NeuroS1  infection,
30  samples  from  8 animals  with  non-suppurative  encephalitis  of  another  etiology  and  30  samples  from
apparently  healthy  slaughtered  animals.  The  IHC  was  positive  only  with  tissue  samples  from  animals
with  a known  positive  BoAstV-CH13/NeuroS1  status,  but not  with  those  from  negative  ones,  indicating
a  good  diagnostic  sensitivity  and  speciﬁcity  of  the  assay.  The  ORF2-con  IHC  procedure  is  therefore  an
adequate  tool  for the  detection  of  BoAstV-CH13/NeuroS1  infections  in  cattle.
©  2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Astroviridae are small viruses with a star-like appearance in
lectron microscopy (Caul and Appleton, 1982). Members of this
amily are non-enveloped viruses and have a positive sense, single-
tranded RNA genome of 6.2 to 7.8 kb. The ﬁrst astrovirus to be
iscovered was isolated in 1975 from stool samples of children
uffering from diarrhea (Appleton and Higgins, 1975). Since then,
stroviruses have been found in the feces of many species but, apart
rom humans (especially children), in which they are recognized
s a leading cause of diarrhea, their association with enteric dis-
Abbreviations: BoAstV, bovine astrovirus; ESBE, European spo-
adic bovine encephalitis; FFPE, formalin-ﬁxed, parafﬁn embedded; NGS,
ext-generation sequencing; IHC, immunohistochemistry; IPTG, isopropyl--
-thiogalactopyranoside; ISH, in situ hybridization; IF, immunoﬂuorescence; ORF,
pen reading frame; RT-PCR, reverse transcription PCR.
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166-0934/© 2016 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ease has not been found to be consistent. In cattle, for example,
animals experimentally infected with a bovine astrovirus (BoAstV)
did not develop clinical disease (Woode and Bridger, 1978; Woode
et al., 1984), and excretion of the virus was  found to be variable
(Alfred et al., 2015; Tse et al., 2011). In recent years, novel astro-
viruses have been found in several cases of encephalitis in different
species: humans (Brown et al., 2015; Cordey et al., 2016; Fremond
et al., 2015; Naccache et al., 2015; Quan et al., 2010; Sato et al., 2016;
Saylor et al., 2015; Thakur and Venkatesan, 2015; Wunderli et al.,
2011), minks (Blomstrom et al., 2010) and cattle (Bouzalas et al.,
2014; Li et al., 2013; Schlottau et al., 2016; Seuberlich et al., 2016). In
cattle, it seems that two different types of neurotropic astroviruses
occur: BoAstV-CH13/NeuroS1 (Bouzalas et al., 2016; Li et al., 2013)
and BoAstV-CH15 (Seuberlich et al., 2016), the latter being very
similar to another bovine neurotropic virus that has been found in
Germany lately (Schlottau et al., 2016). Both have been found in
cases of so-called European sporadic bovine encephalitis (ESBE), a
disease characterized histologically by a non-suppurative inﬂam-
mation pattern (Fankhauser, 1961) but with a heterogeneous, in
some cases unknown etiology. So far, BoAstV-CH15 was  found only
in two  animals, but BoAstV-CH13/NeuroS1 infections seem to be
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ore frequent, as the virus was detected in brain tissues of around
ne quarter of animals with ESBE.
Different methods have been used to detect BoAstV-
H13/NeuroS1: next-generation sequencing (NGS), reverse
ranscription PCR (RT-PCR), and in situ hybridization (ISH)
Bouzalas et al., 2014; Li et al., 2013). NGS has the advantage
f providing details about the sequences found, but is not ade-
uate for testing large number of samples. RT-PCR is a quick
nd handy method. However, both techniques do not allow a
eliable in situ detection of the virus. Procedures that are suitable
or use with formalin-ﬁxed, parafﬁn embedded (FFPE) material,
hich is the most common type of tissue sample in pathology,
acilitate pathogen identiﬁcation on archived material and ret-
ospective prevalence studies. Whereas ISH is a well suited and
ensitive approach to this end, it is technically demanding and
ime-consuming. Therefore, our aim was to develop a robust,
ime-efﬁcient and cost-effective method for the diagnosis and
urther characterization of BoAstV-CH13/NeuroS1 in FFPE tissues.
onsequently, immunohistochemistry (IHC) was the method of
hoice. For this purpose, we expressed ﬁve different recombinant
iral antigens, which were then used for the production of hyper-
mmune sera in rabbits. After optimization of the IHC protocol,
he method was tested on different sets of samples in order to
valuate its accuracy. The hyperimmune serum raised against
he conserved N-terminus of the viral capsid protein provided
ensitive and speciﬁc results in IHC, comparable to those obtained
ith ISH.
. Materials and methods
.1. Design of the recombinant viral antigens
Initially, we attempted to produce three antigens correspond-
ng to the full-length primary translation products of each ORF
ORF1a, ORF1b, ORF2). While we were able to amplify the entire
oding region of ORF1b by RT-PCR, this was not possible for ORF1a
nd ORF2. Therefore, we decided to produce two smaller anti-
ens for each of these latter ORFs instead. ORF1a-p20 and -p26
ere designed on the basis of two known products generated after
roteolysis of the nsp1a precursor protein in human astroviruses
Geigenmuller et al., 2002). ORF2-con and -var correspond to the
onserved and variable regions of Vp90, respectively (Bass and Qiu,
000; Wang et al., 2001) (Fig. 1).
.2. RNA extraction, ampliﬁcation, and cloning
RNA was extracted with TRIzol Reagent (Life Technologies) from
rozen brain tissue of animal 45664, the BoAstV-CH13/NeuroS1
ndex case described in the study of Bouzalas et al. (Bouzalas et al.,
014). Viral RNA was reverse transcribed to cDNA (primer 5′-
TCGGCGTGGCCTCGG-3′) with ThermoScrip RT-PCR System (Life
echnologies), which was then ampliﬁed by PCR with Pfu DNA Poly-
erase (Promega) using the following thermal cycling conditions:
5 ◦C for 2 min, 10 cycles at 95 ◦C for 30 s, 55 ◦C for 30 s, 72 ◦C for 90 s,
5 cycles at 95 ◦C for 30 s, 60 ◦C for 30 s, 72 ◦C for 1 min  + 10 s per
ycle and 72 ◦C for 7 min. The primers included restriction enzyme
ecognition sites that allowed directional cloning into the expres-
ion vector (Supplementary material S1). Each amplicon was ﬁrst
loned into TOPO TA vector (Life Technologies) and transformed
nto One Shot TOP10 Chemically Competent E. coli (Thermo Fisher
cientiﬁc). The insert sequences were veriﬁed by Sanger sequenc-
ng and subcloned into the expression vector pETHis-1 (Schaller
t al., 1999), which encodes for 6× and 10× histidine tags 5′ and
′ to the insert, respectively. The resulting constructs were ﬁnallyal Methods 239 (2017) 26–33 27
transformed into BL21 (DE3) Competent Cells C2527 (New England
Biolabs).
2.3. Western immunoblot
Expression of each recombinant protein was checked by West-
ern blot, which also allowed the optimization of bacterial growth
and expression conditions. Brieﬂy, samples were diluted 1:2 in
Laemmli buffer and boiled at 95 ◦C for 5–10 min. Electrophoresis
of the samples was carried out in hand-casted 10% acrylamide
Tris-glycine gels and transfer was done to nitrocellulose mem-
branes. After blocking in 5% skim-milk for 1 h in PBS-Tween,
membranes were incubated with Mouse Anti Histidine tag, clone
AD1.1.10 (AbD Serotec) antibodies, diluted 1:1000 in 5% skim-milk
in PBS-Tween for 1 h and, following washing, with Polyclonal Rab-
bit Anti-Mouse Immunoglobulins/HRP (Dako), diluted 1:9000, for
45 min. Visualization of protein bands was achieved using 1-Step
Ultra TMB-Blotting Solution (Thermo Fisher Scientiﬁc).
2.4. Recombinant protein expression and puriﬁcation
Six hundred ml  Luria-Bertani medium containing 100 g/ml
ampicillin were inoculated with 25 ml  overnight culture of
transformed BL21 cells and incubated at 37 ◦C on a horizon-
tal shaker until reaching an OD600 of 0.6–0.8. Expression of
recombinant protein was  induced by addition of isopropyl--d-
thiogalactopyranoside (IPTG) to a ﬁnal concentration of 0.5 mM,  the
culture being then incubated for 2 h more. The culture volume was
divided in three, then bacteria were harvested by centrifugation at
4000 × g for 15 min at 4 ◦C, and the resulting pellets were stored
frozen for at least 30 min. Puriﬁcation conditions were optimized
for each of the recombinant proteins (Supplementary material S2).
Lysis of bacteria was performed in 5 ml lysis buffer for 30 min  at
room temperature, either containing 1 mg/l Lysozyme from chicken
egg white (Sigma Aldrich) or 6 M urea. The samples were then son-
icated for 4 min  in iced water with a Branson soniﬁer 250 device
(Emerson Industrial Automation), using the following parameters:
duty cycle 50%, output control 1. The lysates were incubated at 4 ◦C
overnight under gentle agitation, and then cleared by centrifuga-
tion for 30 min  at 12,000 × g and 4 ◦C. Afterwards, each recombinant
His-tagged protein was  immobilized on a HisTrap HP column (GE
Healthcare) using an ÄKTAprime plus device (GE Healthcare) as
follows: ﬁrst, the column was washed with 10 ml binding/washing
buffer, then the lysate was  injected in a 5 ml  fraction. After intensive
washing with 15 ml  binding/washing buffer, the protein was col-
lected in 4 fractions of 1 ml  (E1-E4) through step elution using a PBS
buffer containing 500 mM imidazole. Eluted fractions were ana-
lyzed for protein content and purity by SDS-PAGE and Western blot.
Imidazole was  removed from the eluted fraction containing the
highest quantity of protein by dialysis against in PBS with 1 M urea.
Finally, the protein concentration was controlled using a NanoDrop
1000 Spectrophotometer (Thermo Fisher Scientiﬁc).
2.5. Rabbit immunization
Immunization and blood sample collection was conducted at
Davids Biotechnologie (Regensburg, Germany). Two  rabbits per
antigen were injected s.c., one with 200–600 g of protein in solu-
tion (SuperFast Antiserum protocol) and the other with 50–200 g
of antigen contained in SDS-PAGE gel pieces (LowDose Antiserum
protocol). Pre- and post-immunization sera were collected (1.5 ml
and 90 ml,  respectively) and 45 ml  of each post-immunization
serum was  afﬁnity-puriﬁed. At our institute, all samples were
tested for their speciﬁc reactivity by Western blotting using the
corresponding recombinant proteins.
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Fig. 1. Relation of recombinant antigens to the BoAstV-CH13/NeuroS1 genome and putative viral proteins. Recombinant antigens are depicted in bold and coding regions are
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.6. Immunohistochemistry − pre-assessment
After a ﬁrst screening with 3 different antigen retrieval methods
microwave heating in citrate buffer at pH 6 and pH 9, proteinase
 treatment) and dilutions (1:20, 1:50, 1:100), several parame-
ers were evaluated in order to determine the best performing IHC
rotocol: antigen retrieval method (microwave heating in citrate
uffer at pH 6 and pH 9, microwave heating in urea buffer, pro-
einase K treatment, trypsin treatment, autoclaving in citrate buffer
t pH6, no treatment), dilution (1:10, 1:25, 1:50, 1:100, 1:250,
:500, 1:1000) and incubation time (1 h at 37 ◦C, overnight at 4 ◦C)
f the primary antibody. Each method was tested on a positive
index case 45664) and negative control (animal 49455, tested neg-
tive for BoAstV-CH13/NeuroS1 by RT-PCR and ISH) sample, and the
esulting staining assessed microscopically.
.7. ORF2-con immunohistochemistry
Pre-assessment results led to the establishment of the ﬁnal
HC protocol with ORF2-con hyperimmune serum. FFPE brain tis-
ue was cut to 4 m thick sections. After deparafﬁnization and
ehydration of tissue sections, endogenous peroxidase activity was
locked in a solution of 3% H2O2 in methanol for 15 min. Antigen
etrieval was performed by microwave heating (20 min  at 95 ◦C)
n a Microwave Tissue Processor (EBSciences) in Target Retrieval
olution, pH 9 (Dako). Subsequently, tissue slides were blocked for
5 min  in 10% normal goat serum in PBS-T solution, which was fol-
owed by incubation with afﬁnity-puriﬁed rabbit hyperimmunsera,
iluted 1:100 in PBS-Tween, overnight at 4 ◦C. Antibody detection
as done with Dako REAL Detection System following the manu-
acturer’s instructions and tissue slides were ﬁnally counterstained
ith Mayer’s hemalum solution (Merck Millipore).
.8. Immunohistochemistry − validation procedureThe ORF2-con protocol was further validated using three groups
f samples that were available from the archive of the Division of
eurological Sciences, Vetsuisse Faculty, University of Bern (Bern,1a-p26 and protein products p20, respectively p26 is due to the primer designing
ames of the family Astroviridae; in italics: putative protein products of the family
ino acid; RdRp: RNA-dependent RNA polymerase.
Switzerland): (i) 30 tissue samples originating from 9 BoAstV-
CH13/NeuroS1 positive animals (either in NGS or RT-PCR), (ii) 30
tissue samples from 8 cattle with viral encephalitis of unknown
etiology, which were negative for BoAstV (in NGS, RT-PCR or ISH
assays) and (iii) 30 controls, apparently healthy slaughtered, with-
out histopathological brain lesions and that were tested negatively
in RT-PCR. Animals of the two  ﬁrst groups presented neurological
symptoms and were histologically diagnosed with ESBE. The pro-
tocol was  also tested with a brain sample of animal 42535, which
was found to be positive for BoAstV-CH15 (Seuberlich et al., 2016).
We were also interested to compare the staining obtained in
IHC to that in ISH. To this end, we applied a previously described
ISH protocol (Bouzalas et al., 2014). Both digoxigenin (DIG)-labeled
antisense RNA probes A and B were used.
2.9. Immunoﬂuorescence (IF)
The protocol for IF was  the same as for IHC, until and including
the incubation step with the primary antibody. Then, after wash-
ing 3 × 5 min  with PBS-T, the slides were incubated with Alexa
Fluor 555 goat anti-rabbit antibodies (Abcam) diluted 1:100 in
PBS-Tween for 1–2 h at room temperature and in the dark. DAPI
BioChemica (AppliChem) was  then added in a 1:10,000 dilution
for 30 min. Ultimately, the slides were washed 3 × 5 min  with PBS-
T and 1 × 5 min with distilled water, and mounted with Glycergel
(Dako).
3. Results
3.1. Cloning, recombinant protein expression and puriﬁcation
All ﬁve target sequences were successfully cloned into the
expression vector pETHis-1 and recombinant proteins were pro-
duced by BL21 E. coli, as proteins of the expected molecular
masses could be seen in Western blot with antibodies targeting
the histidine tags (Fig. 2A). However, expression levels varied con-
siderably and for two proteins (ORF1a-p20 and ORF1a-p26) strong
denaturing conditions were required for protein extraction and
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Fig. 2. Detection of recombinant antigens using Western blotting methods. (A) Detection of all ﬁve recombinant antigens obtained 2 h after induction of protein expression,
using anti-His antibodies. Expected molecular weights (kDa), calculated with the ExPASy ProtParam tool (http://web.expasy.org/protparam): ORF1a-p20: 29.8; ORF1a-p26:
28.9;  ORF1b: 63.9; ORF2 con: 41.7; ORF2-var: 36.9. (B) Fractions obtained during protein puriﬁcation of antigen ORF2-con. Controls in panels A and B: BL21 cells with
empty  pETHis vector. (C) Testing of the hyperimmune serum raised against ORF2-con on fraction E2 obtained during puriﬁcation of ORF2-con and a negative control, and
comparison with protein staining performed with anti-His monoclonal antibodies and preimmune serum. The band visible at the approximate molecular weight of ORF2-con
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uriﬁcation. After metal-chelate afﬁnity puriﬁcation, the fractions
ontaining the most protein of interest were E2 and E3 for all
ecombinant proteins (as exempliﬁed for the ORF2-con protein in
ig. 2B). A minimum protein quantity of 0.2 mg  (minimal concen-
ration: 0.3 mg/ml) in solution after dialysis or 50 g in gel pieces
n total was achieved for all proteins, which was considered as
ufﬁcient for rabbit immunization.
.2. Rabbit immunization
All ﬁve hyperimmune sera presented an ELISA titer of 1:30,000
nd at least 0.7 mg/ml  IgG in the afﬁnity-puriﬁed fraction, according
o the data provided by the commercial immunization service. In
ur laboratory, the sera raised against ORF1a-p26, ORF1b, ORF2-
on and ORF2-var, but not the one against ORF1a-p20, clearly
etected the corresponding recombinant antigen when tested for
heir immunoreactivity by Western blotting. Yet, reactivity against
ifferent putative bacterial proteins could be seen when testing
oth pre- and hyperimmune sera. The best result was  systemat-
cally achieved with the afﬁnity-puriﬁed fraction of each serum,
hen compared to the whole serum. The Western blot data for the
erum against ORF2-con are shown as an example in Fig. 2C..3. Immunohistochemistry
Afﬁnity-puriﬁed hyperimmune sera were tested on FFPE brain
issue sections of a BoAstV-CH13/NeuroS1 positive animal and ofrally build an immune response, as this band disappears after afﬁnity-puriﬁcation
ar); pos: fraction E2 obtained after puriﬁcation of ORF2-con; Stars: protein band
a negative one. Sera raised against ORF1a-p20, ORF1a-p26, ORF1b
and ORF2-var showed some immunoreactivity on positive sections,
but diffuse background staining on negative sections as well, even
under optimized conditions (Supplementary material S3). By con-
trast, when using the serum directed against the ORF2-con antigen,
a high number of neurons in the positive sample revealed a strong
diffuse and granular cytoplasmic reactivity that extended into their
processes (Fig. 3A), which was absent in the negative control tissue
(Fig. 3B and C). Based on these results, the IHC protocol using the
serum against ORF2-con was selected for further validation.
3.4. Validation of the ORF2-con IHC procedure
Out of 9 BoAstV-CH13/NeuroS1 positive cattle, 8 showed posi-
tive immunolabeling in at least one brain region tested and were
therefore classiﬁed as positive in the ORF2-con IHC. Labeling was
absent in the BoAstV-CH13/NeuroS1 negative ESBE cases, as well
as in the negative control animals, and consequently these cases
scored IHC negative (Table 1). These results indicate a good diagnos-
tic sensitivity (8/9) and a very good diagnostic speciﬁcity (38/38)
of the ORF2-con IHC.
The amount of immunolabeled cells was  variable between brain
regions as well as between animals (Table 2). For animal 43484, only
one region out of four was positive and the labeling was  discrete,
as only a few small cells and what appeared as cellular processes
were stained. In the remaining IHC positive cases, reactivity was
observed in all brain regions (Table 2).
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Fig. 3. Immunohistochemical detection of BoAstV-CH13/NeuroS1 in bovine brain tissue using hyperimmune antiserum against ORF2-con. (A) BoAstV-CH13/NeuroS1 positive
case.  Positively stained cells are strongly labeled, with the presence of granular material. Note perivascular cufﬁng on the right and gliosis on the left of the picture, which
are  hallmarks of non-suppurative encephalitis. (B) Negative, healthy control animal. (C)
appearing diffusely reddish; however, there is none of the granular dark red labeling as 
legend,  the reader is referred to the web version of this article.)
Table 1
Results of BoAstV-CH13/NeuroS1 detection by immunohistochemistry (IHC) in all
three animal groups tested for the validation of the protocol. ESBE: European spo-
radic bovine encephalitis; +: positive; −: negative;.
IHC ESBEBoAstV+ ESBEBoAstV- Negativecontrols
+ 8 0 0
w
C
d
a
I
t
m
m
B
3
O
i–  1 8 30
Total 9 8 30
In order to compare the performance of the ORF2-con IHC
ith ISH, serial sections of different brain regions of the BoAstV-
H13/NeuroS1 index case 45664 were tested by ISH and IHC. The
issemination of positively stained cells in IHC was very similar in
ll brain regions compared to ISH (Fig. 4A and B). Nonetheless, in
HC, cell staining was more easily recognizable and more uniform,
issue architecture was better conserved and there was in general
uch less background staining compared to ISH. The hyperim-
une serum against ORF2-con apparently does not recognize the
oAstV-CH15 virus, as labeling was absent in animal 42535.
.5. ImmunoﬂuorescenceWe  were interested in whether the hyperimmune serum against
RF2-con is also suitable for the detection of viral antigens by
mmunoﬂuorescence (IF) in FFPE tissues. Although this approach Negative, healthy control animal. Background staining is higher, with some cells
seen in positive cases. (For interpretation of the references to colour in this ﬁgure
was not fully validated, in the index case 45664, the distribution
of positively stained cells was comparable to that in IHC and ISH
(Fig. 4A–C). Staining appeared as granula-like material spread over
the entire cytoplasm of affected cells, including ﬁne processes, and
apart from the nucleus that was clearly visible through DAPI stain-
ing. Based on morphological criteria only, these cells were classiﬁed
as neurons (Fig. 5).
4. Discussion
Considering general knowledge on structural and nonstructural
proteins of Astroviridae, ﬁve different antigens of the neurotropic
astrovirus BoAstV-CH13/NeuroS1 were expressed in E.coli and
puriﬁed by metal-chelate afﬁnity chromatography. Puriﬁed pro-
teins were then used for the production of hyperimmune sera in
rabbits. The polyclonal antibodies obtained were ﬁnally employed
for the development of a reliable detection method for that virus in
FFPE brain tissues.
Although four out of the ﬁve polyclonal antibodies showed
speciﬁc reactivity in Western immunoblot against the correspond-
ing antigen used for immunization, only the hyperimmune serum
against ORF2-con gave a good signal-to-noise ratio in IHC. A ﬁrst
explanation to this may  be linked to insufﬁcient antigen retrieval
in FFPE tissues, as most hyperimmune sera still showed speciﬁc
reactivity against their antigen in Western blotting assays. On the
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oig. 4. Comparison of BoAstV-CH13/NeuroS1 staining using different methods, on
istochemistry. (B) In situ hybridization with probe B. (C) Immunoﬂuorescence; re
agniﬁcation of the respective zone highlighted on the right.
ther hand, the good reactivity of the hyperimmune serum against
RF2-con in IHC could be due to higher expression levels of struc-
ural viral proteins in infected tissues compared to nonstructural
roteins, a fact that is well known for many viruses. The hyper-
mmune serum against ORF1a-p20 was the only one that lacked
eactivity against the corresponding recombinant protein in West-
rn blot and against BoAstV-CH13/NeuroS1 antigens in IHC, which
ay  result from low immunogenicity of the recombinant protein
r from the antibodies being directed primarily against discontin-l tissue sections of a part of the hippocampus of index case 45664. (A) Immuno-
F2-con; blue: DAPI. The inset on the lower corner of each picture shows a higher
uous epitopes, which were not preserved under formalin ﬁxation
and denaturing conditions in Western immunoblot, respectively.
In spite of this, the hyperimmune sera obtained, including those
that did not perform in IHC in a satisfactory manner, will be tested
with different immunological assays, such as immunoprecipitation,
antigen ELISA or in order to study the virus biology, for instance
in cell culture models. Conversely, the antigens produced will be
assed for the development of ELISA techniques to detect virus spe-
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Table 2
Detailed results of BoAstV-CH13/NeuroS1 detection by immunohistochemistry (IHC) in different tissue samples of animals with a known positive status for the virus. NGS:
next-generation sequencing; ISH: in situ hybridization; +: positive; −: negative; nd: not done; numbers in brackets: semi quantitative evaluation of positivity in IHC.
Case no NGS RT-PCR Region ISH IHC
23871 + + brainstem + + (3)
midbrain + + (3)
23985 +  + cerebellum, brainstem + + (3)
cerebellum, brainstem – + (2)
cerebrum cortex + + (3)
26730 + nd cerebellum, brainstem + + (2)
cerebrum (hippocampus) + + (3)
cerebellum, brainstem + + (1)
26875 +  + cerebrum cortex + + (1)
cerebellum, brainstem + + (1)
cerebellum, brainstem + + (3)
brainstem + + (3)
36716 + nd brainstem + + (1)
cerebellum, brainstem + + (2)
cerebellum – + (1)
cerebrum (hippocampus) + + (2)
43484 nd + brainstem – –
brainstem – –
cerebrum (thalamus) + + (1)
cerebrum cortex – –
43660 + nd cerebellum, brainstem + + (1)
cerebellum, brainstem + + (1)
cerebrum (hippocampus) – + (3)
cerebrum cortex – + (1)
43661 + nd brainstem (obex) – –
cerebellum, brainstem – –
50773 nd + brainstem + + (2)
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neuronal and potentially extraneuronal cell types are infected byig. 5. High magniﬁcation of a cell stained with hyperimmune serum against ORF2-
on  in immunoﬂuorescence.
iﬁc antibodies and to conduct seroprevalence estimations in the
attle population.
The ORF2-con IHC protocol was further validated for the purpose
f BoAstV-CH13/NeuroS1 detection in FFPE tissues. None of the
irus negative animals was positive in the ORF2-con IHC. Inversely,
ll but one virus positive animal were positive in the ORF2-con
HC. In animal 43661 BoAstV CH13/NeuroS1 was detected by NGS
ut neither by ISH, nor by IHC. This ﬁnding was unexpected, sincemidbrain + + (3)
cerebrum (hippocampus) + + (3)
cerebrum cortex + + (3)
these last two methods are usually able to detect single infected
cells in larger sections of brain tissue, whereas virus detection by
NGS is done in relatively small tissue samples and may be techni-
cally challenging. We  reported previously the full-length sequence
of the virus isolate in this animal and it was  found to be genet-
ically very similar to the reference strain (Bouzalas et al., 2016).
This argues against this particular isolate being a divergent type of
astrovirus. However, it was also not fully identical to other isolates
sequenced in our previous studies, thus laboratory contamination
of this brain sample appears unlikely. On the other hand, we can-
not exclude an environmental contamination during sampling. It is
worth mentioning that the read-coverage and read–depth in NGS
were low for this particular isolate, a fact that implies a low viral
load. Therefore, these divergent test results may  reﬂect an uneven
virus distribution in the brain tissue, rather than differences in the
detection limit of NGS compared to that of IHC and ISH.
We analyzed sections of the same FFPE blocks of all virus posi-
tive animals by IHC and ISH, which allowed a good comparison of
the sensitivity of both techniques. While all blocks that tested pos-
itive in ISH were also positive in IHC, this was  not the case in the
opposite situation, namely for three animals, IHC detected BoAstV-
CH13/NeuroS1 in more brain regions than ISH (Table 2). This argues
for a slightly higher sensitivity of the ORF2-con IHC compared to the
detection of viral RNA by ISH. Moreover, the IHC protocol is much
faster, easier to perform and preserves the tissue architecture bet-
ter than ISH. In this regard, the new IHC protocol is superior to ISH
and will replace it in routine testing for BoAstVCH13/NeuroS1 in
FFPE brain tissues in our laboratory.
In addition to a pure diagnostic application of the ORF2-con
hyperimmune serum, double-staining IF against ORF2-con and
speciﬁc cell markers would allow to further investigate whichBoAstVCH13/NeuroS1.
This novel IHC tool allows a broader testing of brain tissue of cat-
tle and other species affected with non-suppurative encephalitis of
rologic
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nknown etiology, in retrospective as well as prospective studies.
n that sense, it would be interesting to investigate if the proto-
ol also works for neurotropic bovine astroviruses originating from
ther geographical areas. We  provided ﬁrst evidence that BoAstV-
H15 (which is phylogenetically distinct from the CH13/NeuroS1
pecies) is not detected by the ORF2-con IHC, and the same may
lso count for BoAstV-BH89/14, which has been reported recently
n Germany (Schlottau et al., 2016). IHC techniques for these viruses
ill likely require the development of adapted recombinant anti-
ens and the production of dedicated antibodies.
Many aspects on the relationship of neurotropic astroviruses
nd encephalitis remain unclear. The role of co-infections or
mmunodeﬁciency in disease (as it seems to be the case in humans)
s unknown, pathogenesis and transmission are not elucidated and,
mportantly, nothing is known about a possible zoonotic poten-
ial of these viruses, all of which being elements prompting further
esearch on the topic. With the present study, we have extended
he spectrum of available diagnostic tools, which is a prerequisite
or these research activities.
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